Cardiff Oncology, Inc. (DE:XE7C)

Cardiff Oncology (XE7C) Balance Sheet


Cardiff Oncology Balance Sheet

Cardiff Oncology's total assets for Q4 2023 were $81.64M, a decrease of -7.70% from the previous quarter. DE:XE7C total liabilities were $11.90M for the fiscal quarter, a 11.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 81.64M$ 116.19M$ 149.54M$ 134.73M$ 13.09M
Total Liabilities
$ 11.90M$ 9.85M$ 9.13M$ 6.57M$ 5.78M
Total Equity Gross Minority
$ 69.74M$ 106.34M$ 140.56M$ 128.16M$ 7.31M
Total Capitalization
$ 71.20M$ 108.38M$ 140.42M$ 128.16M$ 7.31M
Preferred Stock Equity
---$ 1.00K$ 60.00
Capital Lease Obligations
---$ 869.00K$ 1.73M
Currency in USD

Cardiff Oncology Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis